Skip Navigation LinksHome > June 2002 - Volume 96 - Issue 6 > Which Formulation of Propofol was Used?
Anesthesiology:
Correspondence

Which Formulation of Propofol was Used?

Kron, Steven S. M.D.

Free Access
Collapse Box

Author Information

In Reply:—
I appreciate Dr. Matsumura's interest. The propofol formulation in my case did not contain metabisulfite.
Regarding the patient's depth of anesthesia, I would like to point out that despite thorough preoxygenation, she desaturated before any airway instrumentation, suggesting that bronchospasm was evolving before intubation. She had received 1 mg midazolam and 50 μg fentanyl and approximately 2.5 mg/kg propofol for induction. I doubt that light anesthesia caused her event.
The philosopher David Hume believed that an effect could never be absolutely attributed to a given cause despite their temporal association. Although there were certainly other possible causes for the problems reported by myself and others, their association with rapacuronium, a newly released drug known to produce mild bronchospasm, made it necessary to report these events to the anesthesia community.
Steven S. Kron, M.D.

Cited By:

This article has been cited 1 time(s).

Anesthesia and Analgesia
Postdural puncture headache: An imaging-guided management protocol
Somri, M; Teszler, CB; Vaida, SJ; Yanovski, B; Gaitini, D; Tome, R; Fradis, M; Gaitini, LA
Anesthesia and Analgesia, 96(6): 1809-1812.
10.1213/01.ANE.0000065907.85109.B0
CrossRef
Back to Top | Article Outline

© 2002 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Share